Labcorp HoldingsLTS:0JSY +2.77%80 Buyback Yield % is 2.39 as of Jul. 01, 2026, which is 6% above its 10-year median of 2.25. GuruFocus rates LTS:0JSY with a GF Score™ of 80/100 and a GF Value™ of $269.33 (Fairly Valued). The stock has 6 warning signs investors should review. Among 89 Medical Diagnostics & Research companies, Labcorp Holdings ranks better than 80.9% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Labcorp Holdings's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0JSY vs DGX, GH, MTD: Buyback Yield % Comparison
For the Diagnostics & Research subindustry, Labcorp Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labcorp Holdings Buyback Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Labcorp Holdings's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labcorp Holdings (LTS:0JSY) has a Buyback Yield % of 2.39 as of Jul. 01, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Labcorp Holdings and its competitors. This is near median its historical median of 2.25. Over the past decade, Labcorp Holdings' Buyback Yield % has ranged from 0.32 to 7.61. According to the industry distribution chart, Labcorp Holdings ranks #17 out of 89 companies in the Medical Diagnostics & Research industry, placing it in the top 19.1%.
Is Labcorp Holdings' Buyback Yield % too high?
Labcorp Holdings' current Buyback Yield % of 2.39 is near median its 10-year median of 2.25. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 7.61. Based on the distribution chart, Labcorp Holdings ranks #17 out of 89 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Labcorp Holdings has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' Buyback Yield % compare to DGX and GH?
According to the Medical Diagnostics & Research industry distribution chart, Labcorp Holdings ranks #17 out of 89 companies for Buyback Yield %. This places Labcorp Holdings in the top 19% of its industry — outperforming the majority of peers. Historically, Labcorp Holdings' own Buyback Yield % has ranged from 0.32 to 7.61 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Diagnostics & Research company?
A good Buyback Yield % depends on the Medical Diagnostics & Research industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Labcorp Holdings and its competitors. Labcorp Holdings's current Buyback Yield % is 2.39, which is near median its own 10-year median of 2.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LTS:0JSY) is currently considered Fairly Valued. The stock's GF Value™ is $269.33, compared to a current price of $280.78 — trading 4.3% above its estimated fair value. The current Buyback Yield % is 2.39, which is near median its 10-year median of 2.25. Labcorp Holdings' overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Labcorp Holdings (LTS:0JSY), the current Buyback Yield % is 2.39 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labcorp Holdings (LTS:0JSY) Overvalued in 2026?
Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued.
The current stock price of $280.78 is trading 4.3% above its estimated GF Value™ of $269.33.
GuruFocus considers Labcorp Holdings to be Fairly Valued.
Key valuation signals for LTS:0JSY:
Buyback Yield %: 2.39 (near median its 10-year median of 2.25)
GF Value™: $269.33 vs. price of $280.78 (4.3% above fair value)
No single metric tells the full story. See the LTS:0JSY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
80GF Score
Get the complete analysis for LTS:0JSY
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0JSY has been successfully added to your 
